会員登録
ログイン
【3537】昭栄薬品
化学品の商社。オレオケミカルなど。
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025.03 | 2024/08/07 | Q1予 | 22,677 | → | 0.0% | 0.0% | 343 | → | 0.0% | 0.0% | 503 | → | 0.0% | 0.0% | 348 | → | 0.0% | 0.0% |
| 2025.03 | 2024/05/13 | 当初予 | 22,677 | - | - | - | 343 | - | - | - | 503 | - | - | - | 348 | - | - | - |
| 2024.03 | 2024/05/13 | 実 | 22,595 | ↑ | +1.0% | -6.8% | 440 | ↑ | +4.8% | +33.7% | 651 | ↑ | +7.1% | +35.6% | 491 | ↑ | +15.5% | +41.5% |
| 2024.03 | 2024/02/06 | Q3予 | 22,366 | ↓ | -7.7% | -7.7% | 420 | ↑ | +27.7% | +27.7% | 608 | ↑ | +26.7% | +26.7% | 425 | ↑ | +22.5% | +22.5% |
| 2024.03 | 2023/11/09 | Q2予 | 24,232 | → | 0.0% | 0.0% | 329 | → | 0.0% | 0.0% | 480 | → | 0.0% | 0.0% | 347 | → | 0.0% | 0.0% |
| 2024.03 | 2023/08/04 | Q1予 | 24,232 | → | 0.0% | 0.0% | 329 | → | 0.0% | 0.0% | 480 | → | 0.0% | 0.0% | 347 | → | 0.0% | 0.0% |
| 2024.03 | 2023/05/11 | 当初予 | 24,232 | - | - | - | 329 | - | - | - | 480 | - | - | - | 347 | - | - | - |
| 2023.03 | 2023/05/11 | 実 | 24,529 | ↑ | +2.7% | +19.3% | 488 | ↑ | +17.3% | +87.0% | 673 | ↑ | +10.5% | +67.0% | 484 | ↑ | +11.3% | +74.7% |
| 2023.03 | 2023/02/07 | Q3予 | 23,883 | → | 0.0% | +16.2% | 416 | → | 0.0% | +59.4% | 609 | → | 0.0% | +51.1% | 435 | → | 0.0% | +57.0% |
| 2023.03 | 2022/11/09 | Q2予 | 23,883 | ↑ | +16.2% | +16.2% | 416 | ↑ | +59.4% | +59.4% | 609 | ↑ | +51.1% | +51.1% | 435 | ↑ | +57.0% | +57.0% |
| 2023.03 | 2022/08/05 | Q1予 | 20,555 | → | 0.0% | 0.0% | 261 | → | 0.0% | 0.0% | 403 | → | 0.0% | 0.0% | 277 | → | 0.0% | 0.0% |
| 2023.03 | 2022/05/12 | 当初予 | 20,555 | - | - | - | 261 | - | - | - | 403 | - | - | - | 277 | - | - | - |
| 2022.03 | 2022/05/12 | 実 | 21,147 | ↑ | +2.2% | +20.7% | 302 | ↑ | +14.4% | +98.7% | 474 | ↑ | +11.3% | +55.4% | 578 | ↑ | +7.2% | +170.1% |
| 2022.03 | 2022/02/08 | Q3予 | 20,692 | ↑ | +18.1% | +18.1% | 264 | ↑ | +73.7% | +73.7% | 426 | ↑ | +39.7% | +39.7% | 539 | ↑ | +151.9% | +151.9% |
| 2022.03 | 2021/11/08 | Q2予 | 17,520 | → | 0.0% | 0.0% | 152 | → | 0.0% | 0.0% | 305 | → | 0.0% | 0.0% | 214 | → | 0.0% | 0.0% |
| 2022.03 | 2021/08/06 | Q1予 | 17,520 | → | 0.0% | 0.0% | 152 | → | 0.0% | 0.0% | 305 | → | 0.0% | 0.0% | 214 | → | 0.0% | 0.0% |
| 2022.03 | 2021/05/13 | 当初予 | 17,520 | - | - | - | 152 | - | - | - | 305 | - | - | - | 214 | - | - | - |
| 2021.03 | 2021/05/13 | 実 | 17,032 | ↑ | +5.5% | -5.9% | 157 | ↑ | +38.9% | +29.8% | 313 | ↑ | +23.7% | +19.5% | 237 | ↑ | +34.7% | +33.1% |
| 2021.03 | 2021/02/05 | Q3予 | 16,141 | → | 0.0% | -10.8% | 113 | → | 0.0% | -6.6% | 253 | → | 0.0% | -3.4% | 176 | → | 0.0% | -1.1% |
| 2021.03 | 2020/11/06 | Q2予 | 16,141 | ↓ | -10.8% | -10.8% | 113 | ↓ | -6.6% | -6.6% | 253 | ↓ | -3.4% | -3.4% | 176 | ↓ | -1.1% | -1.1% |
| 2021.03 | 2020/08/07 | Q1予 | 18,103 | → | 0.0% | 0.0% | 121 | → | 0.0% | 0.0% | 262 | → | 0.0% | 0.0% | 178 | → | 0.0% | 0.0% |
| 2021.03 | 2020/05/11 | 当初予 | 18,103 | - | - | - | 121 | - | - | - | 262 | - | - | - | 178 | - | - | - |
| 2020.03 | 2020/05/11 | 実 | 17,733 | ↓ | -0.6% | -15.0% | 128 | ↑ | +6.7% | -54.3% | 262 | ↑ | +2.3% | -36.4% | 255 | ↑ | +9.9% | -6.6% |
| 2020.03 | 2020/02/07 | Q3予 | 17,841 | → | 0.0% | -14.5% | 120 | → | 0.0% | -57.1% | 256 | → | 0.0% | -37.9% | 232 | → | 0.0% | -15.0% |
| 2020.03 | 2019/11/08 | Q2予 | 17,841 | → | 0.0% | -14.5% | 120 | → | 0.0% | -57.1% | 256 | → | 0.0% | -37.9% | 232 | → | 0.0% | -15.0% |
| 2020.03 | 2019/11/05 | 修正予 | 17,841 | ↓ | -14.5% | -14.5% | 120 | ↓ | -57.1% | -57.1% | 256 | ↓ | -37.9% | -37.9% | 232 | ↓ | -15.0% | -15.0% |
| 2020.03 | 2019/08/08 | Q1予 | 20,869 | → | 0.0% | 0.0% | 280 | → | 0.0% | 0.0% | 412 | → | 0.0% | 0.0% | 273 | → | 0.0% | 0.0% |
| 2020.03 | 2019/05/10 | 当初予 | 20,869 | - | - | - | 280 | - | - | - | 412 | - | - | - | 273 | - | - | - |
| 2019.03 | 2019/05/10 | 実 | 20,110 | ↓ | -2.9% | -2.9% | 273 | ↓ | -13.6% | -13.6% | 411 | ↓ | -5.7% | -5.7% | 272 | ↓ | -9.0% | -9.0% |
| 2019.03 | 2019/02/08 | Q3予 | 20,700 | → | 0.0% | 0.0% | 316 | → | 0.0% | 0.0% | 436 | → | 0.0% | 0.0% | 299 | → | 0.0% | 0.0% |
| 2019.03 | 2018/11/09 | Q2予 | 20,700 | → | 0.0% | 0.0% | 316 | → | 0.0% | 0.0% | 436 | → | 0.0% | 0.0% | 299 | → | 0.0% | 0.0% |
| 2019.03 | 2018/08/02 | Q1予 | 20,700 | - | - | - | 316 | - | - | - | 436 | - | - | - | 299 | - | - | - |
| 2018.03 | 2018/02/09 | Q3予 | 19,554 | → | 0.0% | 0.0% | 324 | → | 0.0% | 0.0% | 381 | → | 0.0% | 0.0% | 262 | → | 0.0% | 0.0% |
| 2018.03 | 2017/11/10 | Q2予 | 19,554 | → | 0.0% | 0.0% | 324 | → | 0.0% | 0.0% | 381 | → | 0.0% | 0.0% | 262 | → | 0.0% | 0.0% |
| 2018.03 | 2017/08/08 | Q1予 | 19,554 | → | 0.0% | 0.0% | 324 | → | 0.0% | 0.0% | 381 | → | 0.0% | 0.0% | 262 | → | 0.0% | 0.0% |
| 2018.03 | 2017/05/10 | 当初予 | 19,554 | - | - | - | 324 | - | - | - | 381 | - | - | - | 262 | - | - | - |
| 2017.03 | 2017/05/10 | 実 | 18,828 | ↓ | -1.9% | -1.9% | 297 | ↑ | +4.6% | +4.6% | 389 | ↑ | +11.1% | +11.1% | 261 | ↑ | +8.7% | +8.7% |
| 2017.03 | 2017/02/10 | Q3予 | 19,194 | → | 0.0% | 0.0% | 284 | → | 0.0% | 0.0% | 350 | → | 0.0% | 0.0% | 240 | → | 0.0% | 0.0% |
| 2017.03 | 2016/11/11 | Q2予 | 19,194 | → | 0.0% | 0.0% | 284 | → | 0.0% | 0.0% | 350 | → | 0.0% | 0.0% | 240 | → | 0.0% | 0.0% |
| 2017.03 | 2016/05/12 | 当初予 | 19,194 | - | - | - | 284 | - | - | - | 350 | - | - | - | 240 | - | - | - |
| 2016.03 | 2016/05/12 | 実 | 18,406 | - | - | - | 283 | - | - | - | 326 | - | - | - | 759 | - | - | - |
